Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Contract revenue	$ 845,185	$ 639,558
Grant revenue	79,367	505,230
Total revenues	924,552	1,144,788
Cost of revenues	(829,506)	(927,924)
Gross profit	95,046	216,864
Operating expenses:
Research and development	2,700,171	1,642,718
General and administrative	868,667	874,209
Research and development expense - milestone	5,000,000
Total operating expenses	8,568,838	2,516,927
Loss from operations	(8,473,792)	(2,300,063)
Foreign currency transaction (loss)/gain	(23,232)	5,007
Interest income	21,947	44,753
Research and development incentives	56,850
Net loss before income taxes	(8,418,227)	(2,250,303)
Income tax benefit	836,893	610,676
Net loss	$ (7,581,334)	$ (1,639,627)
Basic and diluted net loss per share	$ (0.32)	$ (0.09)
Basic and diluted weighted average common shares outstanding	23,404,920	18,078,951